<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890119</url>
  </required_header>
  <id_info>
    <org_study_id>AMYLYONCARP</org_study_id>
    <nct_id>NCT04890119</nct_id>
  </id_info>
  <brief_title>Prevalence Study of Amyloidosis in Patients With Surgery of Suspect Bilateral Carpal Tunnel (AMYLYONCARP)</brief_title>
  <acronym>AMYLYONCARP</acronym>
  <official_title>Prevalence Study of Amyloidosis in Patients With Surgery of Suspect Bilateral Carpal Tunnel (AMYLYONCARP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Saint Joseph Saint Luc de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Saint Joseph Saint Luc de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the prevalence of amyloidosis in population of&#xD;
      patient affected by suspect bilateral carpal tunnel with indication of surgery&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of amyloid aggregate</measure>
    <time_frame>During surgery</time_frame>
    <description>Research of amyloid aggregate in tenosynovial tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Typing of amyloid aggregate</measure>
    <time_frame>During surgery</time_frame>
    <description>Caracterization of amyloid aggregate in tenosynovial tissue</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Research of organ amyloidosis (context of standard care): exploratory</measure>
    <time_frame>in the 3 months following surgery</time_frame>
    <description>Among positive patients, additional exams will be performed in the context of standard care in order to research for organ amyloidosis: blood sampling, EKG, echocardiography and other organ exams according to type of amyloidosis</description>
  </other_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Carpal Tunnel Syndrome Bilateral</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>tenosynovial tissue biopsy</intervention_name>
    <description>Biopsy of tenosynovial tissue during surgery for amyloid aggregate search</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  bilateral carpal tunnel with indication of surgery and judged suspect:&#xD;
&#xD;
          -  age of 50 years old and more&#xD;
&#xD;
          -  non-traumatic or undetermined neuropathic etiology or cardiac history (atrial&#xD;
             arrhythmia or Heart Failure or cardiac stimulation) or family history of hereditary&#xD;
             amyloidosis or monoclonal gammopathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient with diagnosis of amyloidosis&#xD;
&#xD;
          -  traumatic bilateral carpal tunnel or linked to rheumatoid arthritis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe SCHIELE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Saint Joseph Saint Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe SCHIELE, MD</last_name>
    <email>pschiele@chsjsl.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa GREEN, MD</last_name>
    <phone>478 618 602</phone>
    <phone_ext>+33</phone_ext>
    <email>lgreen@chsjsl.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Joseph Saint Luc</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>St√©phane Rio</last_name>
      <email>srio@chsjsl.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe SCHIELE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille BARANI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

